Many studies have shown that tumor emergence and growth are associated with changes in DNA methylation patterns, such as the case of prostate cancer development. Therefore, one of the most important application areas for epigenetic research is in the diagnosis and treatment of cancer — using DNA methylation patterns to detect cancer at very early stages, to classify tumors, and to predict and monitor response to drug treatments. QIAGEN’s dedicated solutions for epigenetics facilitate cancer research and help to overcome bottlenecks that have existed in screening, identification, and quantification of CpG sites in methylation analysis.
Show details